Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.02082
European Journal of Endocrinology, Vol 154, Issue 2, 349-354
Copyright © 2006 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jansson, J.-O.
Right arrow Articles by Ohlsson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jansson, J.-O.
Right arrow Articles by Ohlsson, C.

EXPERIMENTAL STUDY

Leukemia inhibitory factor reduces body fat mass in ovariectomized mice

John-Olov Jansson, Sofia Movérare-Skrtic, Anna Berndtsson, Ingrid Wernstedt, Hans Carlsten1 and Claes Ohlsson

Research Center for Endocrinology and Metabolism and 1 Department of Rheumatology and Inflammation Research, Department of Internal Medicine, University of Göteborg, Sweden

(Correspondence should be addressed to J-O Jansson, Department of Phsyiology/Endocrine Section, Medicinargatan 9A, SE413 45 Göteborg, Sweden; Email: JOJ{at}medic.gu.se)

Objective: Ovariectomized (OVX) mice are known to gain body fat while exposure to estrogens decreases fat mass. We have previously shown that estrogen replacement therapy enhances the expression of receptors for the cytokine, leukemia inhibitory factor (LIF). LIF and other cytokines acting via the gp130 signal transducing receptor have been reported to decrease obesity. In the present study, we investigated whether LIF treatment can reduce obesity in OVX mice.

Design: Eight-week-old female C57Bl/6 mice were OVX or sham-operated. The mice were treated with LIF, 30 µg/kg or PBS via daily i.p. injections for 15 days (n = 9–10).

Methods: Dual X-ray absorptiometry and computerized tomography.

Results: We found that LIF treatment of OVX mice caused a significant reduction in the weight of white fat depots (P = 0.017) and serum leptin levels (P = 0.011). LIF also caused a significant decrease in brown fat mass (P = 0.036). Treatment with LIF decreased thymus weight but did not affect crown-rump length, femur length, trabecular bone mineral density or the weight of several non-fat organs including the uterus.

Conclusion: The cytokine, LIF, decreases body fat mass in OVX mice, suggesting that estrogen signaling is not required for this effect.




This article has been cited by other articles:


Home page
Stem CellsHome page
C. Elabd, A. Basillais, H. Beaupied, V. Breuil, N. Wagner, M. Scheideler, L.-E. Zaragosi, F. Massiera, E. Lemichez, Z. Trajanoski, et al.
Oxytocin Controls Differentiation of Human Mesenchymal Stem Cells and Reverses Osteoporosis
Stem Cells, September 1, 2008; 26(9): 2399 - 2407.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 European Society of Endocrinology.